chartexchange

NVO
Novo-Nordisk A/S
stockNYSEADR

Market OpenNov 3, 2026 10:46:09 AM EST
40.54USD+0.235%(+0.09)2,475,962
Pre-marketNov 3, 2026 9:29:59 AM EST
40.33USD-0.309%(-0.13)
40.54Bid40.55Ask0.01Spread
Loading…
Loading…
178.76B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$40.44
Beta
0.95
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$41.11
SMA 200
$44.11
Avg. Vol 10D
9.70M
Avg. Vol 30D
12.11M
Avg. Vol 90D
11.96M
Relative Vol
0.18
3.17B
37,436,108
0.2800%
10,000,000
1,902
Nov 4, 2026 (1d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
NVO Profile

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.

NVO Performance
PeriodPriceDateChangeBeta
1W38.672026-10-27+4.81%-1.294
1M37.322026-10-02+8.60%-0.329
3M47.092026-08-03-13.93%-0.388
6M44.392026-05-04-8.70%-0.134
1Y49.112025-11-03-17.47%0.950
2Y109.722024-11-04-63.06%—
5Y57.782021-11-03-29.86%0.662
NVO Stock Summary

Novo-Nordisk A/S (NYSE:NVO) stock price today is $40.53, and today's volume is 2,186,419. NVO is up 0.197% today. The 30 day average volume is 12.11M. NVO market cap is $178.76B with 4.41B shares outstanding.